Location History:
- Bethesda, MA (US) (2003)
- Hamburg, DE (2006)
- Bethesda, MD (US) (2006)
Company Filing History:
2 out of 90 
1 out of 15,528 
Years Active: 2003-2006
Title: Ulrich Schubert: Innovator in Lentiviral Research
Introduction
Ulrich Schubert is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of lentiviral research, particularly in developing methods to combat lentivirus infections. With a total of three patents to his name, Schubert's work focuses on innovative approaches to inhibit viral replication.
Latest Patents
Schubert's latest patents include groundbreaking methods for identifying agents that inhibit lentivirus replication. One patent provides screening methods for identifying compounds that induce the loss of the lentiviral protein Vpr. Another patent details methods for inhibiting the peptidyl-prolyl cis/trans isomerase (PPIase) activity of a protein that catalyzes the isomerization of cis-peptidylprolyl bonds in Vpr. These compounds are crucial for treating lentiviral infections. Additionally, he has developed synthetic peptides derived from the viral regulatory protein R (Vpr) of HIV-1, which are utilized in biological assays and the development of anti-Vpr antibodies.
Career Highlights
Throughout his career, Ulrich Schubert has worked with esteemed institutions such as the J. David Gladstone Institutes and the University of California. His research has significantly advanced the understanding of lentiviral mechanisms and potential therapeutic targets.
Collaborations
Schubert has collaborated with notable colleagues, including